RDHL Stock Ownership Activity
REDHILL BIOPHARMA LTD-SP ADR 13F holders
No value investing guru has made any change to the REDHILL BIOPHARMA LTD-SP ADR (RDHL) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying RDHL now?
According to the latest SEC filing(s) REDHILL BIOPHARMA LTD-SP ADR (RDHL) has not been purchased by any super investor.
To see more about who is investing in REDHILL BIOPHARMA LTD-SP ADR (RDHL), please go to the RDHL ownership page.
2022 Q3
(1 result)
Current price: $6.78
80.51%
Reported price*: $34.79
2022 Q2
(1 result)
Current price: $6.78
80.51%
Reported price*: $34.79
2022 Q1
(1 result)
Current price: $6.78
93.27%
Reported price*: $100.80
2021 Q4
(1 result)
Current price: $6.78
93.43%
Reported price*: $103.20
2021 Q2
(1 result)
Current price: $6.78
97.54%
Reported price*: $275.20
2021 Q1
(1 result)
Current price: $6.78
97.68%
Reported price*: $292.79
2020 Q4
(1 result)
Current price: $6.78
97.90%
Reported price*: $323.20
2020 Q3
(1 result)
Current price: $6.78
98.34%
Reported price*: $408.80
2020 Q2
(1 result)
Current price: $6.78
97.47%
Reported price*: $268.00
2020 Q1
(1 result)
Current price: $6.78
96.26%
Reported price*: $181.19
2019 Q4
(1 result)
Current price: $6.78
97.21%
Reported price*: $242.80
2019 Q3
(1 result)
Current price: $6.78
97.59%
Reported price*: $281.61
2019 Q2
(1 result)
Current price: $6.78
97.39%
Reported price*: $260.00
2019 Q1
(1 result)
Current price: $6.78
97.96%
Reported price*: $332.41
2018 Q4
(1 result)
Current price: $6.78
96.95%
Reported price*: $222.01
2018 Q3
(1 result)
Current price: $6.78
98.08%
Reported price*: $353.34
16 of 16
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.